Natera (NTRA) Liabilities and Shareholders Equity (2014 - 2026)
Natera (NTRA) reported Liabilities and Shareholders Equity of $2.6 billion for Q1 2026, up 50.91% on a YoY basis from $1.7 billion in Q1 2025, and up 9.01% quarter-over-quarter from $2.4 billion in Q4 2025.
Natera (NTRA) Liabilities and Shareholders Equity (2014 - 2026) Analysis & Trends
Natera has reported Liabilities and Shareholders Equity for 13 years, with the latest figure at $2.6 billion in Q1 2026.
- For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 50.91% year-over-year to $2.6 billion; the trailing twelve-month figure through Mar 2026 stood at $8.6 billion (up 32.15% YoY), and the FY2025 full-year result was $2.4 billion, up 44.41% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $2.6 billion, up from $2.4 billion in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $2.6 billion in Q1 2026, with the low at $1.0 billion in Q3 2022.
- Historically, Liabilities and Shareholders Equity has averaged $1.6 billion across 5 years, with a median of $1.5 billion in 2024.
- Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity dropped 23.05% — and 2026, when it jumped 50.91%.
- Natera's Liabilities and Shareholders Equity stood at $1.4 billion in 2022, then climbed by 3.39% to $1.4 billion in 2023, then climbed by 15.19% to $1.7 billion in 2024, then soared by 44.41% to $2.4 billion in 2025, then grew by 9.01% to $2.6 billion in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $2.6 billion (Q1 2026), $2.4 billion (Q4 2025), and $1.8 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 24.53 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 113.28 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 83.54 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 3.39 Bn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 13.07 Bn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 2.61 Bn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 29.68 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 6.56 Bn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 3.67 Bn |
| 10 | Quest Diagnostics | 22.51 Bn | 22.42 Bn | 942.00 Mn | 16.67 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.61 Bn |
| Dec 31, 2025 | 2.40 Bn |
| Sep 30, 2025 | 1.82 Bn |
| Jun 30, 2025 | 1.76 Bn |
| Mar 31, 2025 | 1.73 Bn |
| Dec 31, 2024 | 1.66 Bn |
| Sep 30, 2024 | 1.59 Bn |
| Jun 30, 2024 | 1.52 Bn |
| Mar 31, 2024 | 1.47 Bn |
| Dec 31, 2023 | 1.44 Bn |
| Sep 30, 2023 | 1.45 Bn |
| Jun 30, 2023 | 1.25 Bn |
| Mar 31, 2023 | 1.32 Bn |
| Dec 31, 2022 | 1.39 Bn |
| Sep 30, 2022 | 1.01 Bn |
| Jun 30, 2022 | 1.07 Bn |
| Mar 31, 2022 | 1.14 Bn |
| Dec 31, 2021 | 1.24 Bn |
| Sep 30, 2021 | 1.31 Bn |
| Jun 30, 2021 | 849.96 Mn |